Find Oncologists

By Editorial Team
Information is a powerful tool when you or a loved one is facing a critical healthcare decision—especially when selecting a hospital or care team for cancer treatment. This choice can directly impact lives, making it essential to choose wisely.

One of the things cancer patients often experience is that everyone around them seems to have advice—drink this, take that, see this therapist, stop eating certain foods, start eating others. It can quickly become overwhelming. For patients, it’s a new and unfamiliar situation, and they often lack the experience to navigate it effectively.

The real danger is that patients may try to do too much, picking bits and pieces from different recommendations. A sense of panic can creep in, fueled by the fear of missing out on something that could help. This vulnerability also leaves them at greater risk of falling for unproven or even harmful "miracle cures" promoted by unscrupulous individuals.

This is why we strongly recommend seeking out a qualified practitioner or clinic where you can receive a personalized, integrated program under the guidance of a dedicated specialist—someone who is a real professional with experience in treating your specific type of cancer.

Find Oncologists (Cancer Specialists) in USA

The Find an Oncologist Database is made available by ASCO (American Society of Clinical Oncology) as an informational resource for patients and caregivers. The database includes the names of physicians and other health professionals from certain ASCO membership categories who have given their permission to be identified publicly: Find a Cancer Doctor

Find Oncologists (Cancer Specialists) in USA

World's Best Cancer Hospitals 2024-2025

Information is a powerful tool when you or someone you love is facing an important health care decision, especially one that requires selecting a hospital or care team. 

Find Integrative Oncologists in USA, Mexico, Europe or Asia

Note: While the term "alternative" might suggest opposition to conventional oncology, we prefer using "complementary," "integrated," or "holistic." These terms better capture the role of these approaches as part of a personalized, value-added menu of strategies designed to provide the most effective and safe solutions for patients. The focus is not on choosing one strategy over another but on combining all available approaches to achieve the best possible outcome.

Clinics Prescribing Ivermectin, Mebendazole, and Related Protocols

Prescribing ivermectin and mebendazole for cancer is off-label and typically occurs in integrative, functional, or alternative medicine settings, often as adjuncts to standard care. These drugs are explored based on preclinical evidence (e.g., ivermectin inhibiting tumor growth in models; mebendazole disrupting microtubules). Availability varies by country; in the US, compounding pharmacies may customize doses. Always consult a licensed provider, as self-medication risks interactions or inefficacy. Below is a list of clinics and providers known to prescribe or incorporate these drugs/protocols, based on patient reports, protocols, and research.

Care Oncology Clinic
  • Location & Contact:
    • US (virtual consultations; physical sites in select areas) & UK
    • Care Oncology. 3705 Saunders Avenue, Richmond, VA 23227.
    • Email: info@careoncology.com

  • Details: Specializes in metabolic oncology; COC Protocol includes mebendazole (100 mg/day, often with metformin, atorvastatin, doxycycline) to disrupt cancer cell energy. May combine with ivermectin in custom plans. Focuses on adjunctive therapy for various cancers (e.g., glioma). Consultations start at ~$500; drugs prescribed via affiliated pharmacies. 
  • Website: careoncology.com (US and Canada)
Internal Healing & Wellness MD
  • Location: Shenandoah, TX, US
  • Details: Functional medicine clinic prescribing ivermectin and fenbendazole (analogous to mebendazole) for cancer. Uses protocols like ivermectin + fenbendazole + vitamin E/curcumin/CBD for immune modulation and cell repair. Offers personalized plans; contact: 255 Ed English Dr, Suite A, (281) 651-2352.
  • Website: internalhealingandwellnessmd.com
Riordan Clinic
  • Location: Wichita, KS, US 
  • Details: Integrative oncology with IV vitamin C (key in hybrid protocols); associated with mitochondrial-stem cell targeting. Likely open to repurposed drugs like ivermectin/mebendazole in custom plans, though not explicitly listed. Focuses on nutritional testing and holistic care.
  • Riordan Clinic in Overland Park, Kansas, United States (X.com)
  • Website: riordanclinic.org
Hope4Cancer Treatment Centers
  • Location: Cancun & Tijuana, Mexico 
  • Details: Alternative/integrative clinics using root-cause approaches; incorporates ivermectin protocols (inspired by Dr. Makis) for shrinking tumors (e.g., breast cancer). Combines with bio-immunotherapy, detox, and nutrition. Costs ~$30,000–50,000 for 3-week programs; international patients welcome.
  • Hope4Cancer in Playas de Tijuana or Cancun, Mexico (source, source)
  • Website: hope4cancer.com
Dr. William Makis' Clinic (via COVID19CriticalCare.com or Substack)
  • Location: Virtual (Canada-based, serves global patients) 
  • Details: Oncology specialist offering ivermectin/fenbendazole/mebendazole protocols for various cancers (e.g., rectal, prostate). World's largest ivermectin cancer clinic; reports dramatic responses (e.g., 70% CEA drop). Consultations via telehealth; dosages: ivermectin 0.5–2.5 mg/kg daily, fenbendazole 222–1,000 mg/day. 
  • Dr William Makis posted this alert on X/Twitter (Jan 2025):
    There are many SCAMS now using my photos on Facebook, WhatsApp and Telegram. I am NOT on any of these platforms! I also don't have a website. 
    You can only reach me via: makisw79@yahoo.com. Any other variation of this email is a fraud.
  • Website: makismd.substack.com
Integrated Medical Alliance (previously FLCCC)-Affiliated Providers
  • Location: US & global (directory available) 
  • Details: FLCCC's Cancer Care guide by Dr. Paul Marik includes ivermectin, mebendazole, and niclosamide as anti-cancer agents. Providers prescribe for adjunctive use; check directory for oncologists/integrative docs. 
  • Website: https://imahealth.org/providers/
City of Hope Cancer Center
  • Location: Duarte, CA, US (clinical trials) 
  • Details: Conducts trials with ivermectin + pembrolizumab for triple-negative breast cancer; may prescribe in trial settings. Not routine off-label. 
  • Website: cityofhope.org
The Wellness Company (twc.health)
  • Medical Specialty: Family Medicine, Functional Medicine
  • Serving all 50 states in the USA (Telemedicine or online consultation)
  • Website: twc.health
Other References (listed in no particular order):
  1. The Karlfeld Center in Idaho, United States (website, Joe Tippens' interview with Dr Karlfeld)
  2. AM Medical LLC, an integrative health clinic serving patients in Washington State (www.ammedicalmd.com)
  3. Dr. LaValley is a fully licensed MD in Texas and Nova Scotia Canada since 1988. He is a professional expert consultant to your medical doctor about your case, not your direct treating physician. Dr. LaValley can be reached at www.LaValleyMDProtocols.com.
  4. Oasis of Hope in Mexico (source)
  5. ChemoThermia Oncology Center in Turkey (source)
Related: Best Alternative Cancer Treatment Centers in the United States

Integrated Medical Alliance (previously FLCCC) Observational Cancer Study: Participating Providers

The FLCCC Alliance is proud to announce it has partnered with renowned breast cancer physician and researcher Kathleen Ruddy, MD, to conduct an observational study in collaboration with five U.S. clinics to track patient responses to various adjunct cancer therapies using repurposed drugs.

Dr. Ruddy and Dr. Paul Marik will act as lead investigators with Dr. Pierre Kory acting as contributing author. Five clinics will participate in the study:
  • Health and Healing, led by Kathleen T. Ruddy, MD
  • Leading Edge Clinic, led by Pierre Kory, MD, MPA and Scott Marsland, FNP-C
  • The James Clinic, led by Mollie James, DO, MPH, FACOS FACS, IFMCP
  • Meakin Metabolic Care, led by Charles Meakin, MD
1. Health and Healing: Kathleen T. Ruddy, MD

Dr. Ruddy is a retired cancer surgeon trained at Memorial Sloan-Kettering Cancer Center. During her 28 years in practice, she took care of more than 10,000 patients in the United States and abroad. She has a Masters degree in International Healthcare Leadership from McGill University. She served on the Leadership Council of the Harvard School of Public Health and was deeply involved in mobilizing international support for West Africa during the outbreak of Ebola in 2014. Dr. Ruddy authored the first book about the human breast cancer virus, The End of Breast Cancer: A Virus and the Hope for a Vaccine. She is now a scientific investigator in an observational study whose objective is to answer the question, "Do repurposed, FDA-approved drugs like ivermectin improve the survival of patients with cancer?"

Telemedicine Appointments Only. 

Contact:
  • Kathleenmrca@aol.com,
  • (201) 323-2288
Address: 46 Green Village Road, Madison, New Jersey 07940

2. Leading Edge Clinic

Pierre Kory, MD, MPA
Scott Marsland, FNP-C

The Leading Edge Clinic, led by Pierre Kory and Scott Marsland, offers specialized evaluation and individualized treatment plans for COVID-19, Long COVID, COVID vaccine injury syndromes, General medicine and Integrated conventional complementary cancer treatment via telehealth. Our care is based on deep scientific study, national and global clinical practice experience, and compassion to meet the whole-person needs of patients.

For anyone in need of treatment for cancer (note we are one of the treatment sites for the repurposed drug trial in cancer described here) or for Long Covid, Long Vax, Hormone Rebalancing, Weight Loss or General Medical Care, feel free to visit the Leading Edge Tele-Health Clinic (we see patients in all 50 states).
 
Telemedicine Appointments Only.

Contact: 
  • Tisha Palmer, Practice Manager 
  • practicemanager@drpierrekory.com 
  • Register as a patient and fill out intake forms at New tab 
  • https://drpierrekory.com/ 
  • (608) 400-0141 
Address: 213 Tioga St, #6834, Ithaca, New York 14851-9997

3. The James Clinic: Mollie James, DO, MPH, FACOS FACS, IFMCP

Dr. James is board certified in general surgery and critical care medicine. She trained at Mercy Medical Center-Des Moines and the University of Minnesota. After practicing for five years, she realized she needed additional tools to help her patients. Functional medicine was the answer. She combined functional medicine into her surgery practice for patients with GI issues presenting for endoscopy and it had immediate benefit to patients. The James Clinic was launched to fulfill the unmet needs of patients, which became even more obvious during 2020. Providing convenient, accessible care and a direct physician-patient relationship without conflicts of interest.

In-person & Telemedicine Appointments.
 
Contact: 
  • hello@jamesclinic.com 
  • https://jamesclinic.com/request-a-consult 
  • (636) 751-9440 
Address: 934 North 7th Street, Chariton, Iowa 50049
States: AR, IA, IL, KY, MI, MO, NC, OK


For more information about the Study, visit https://drpierrekory.com/cancer-care-study.

Oncologists and Integrative Cancer Specialists Familiar with Seyfried's Press-Pulse Protocol in the US

Thomas Seyfried's Press-Pulse protocol is an emerging metabolic approach to cancer treatment, emphasizing the restriction of glucose and glutamine (the "press") combined with targeted interventions like hyperbaric oxygen or drugs (the "pulse") to exploit cancer cells' metabolic vulnerabilities. While it's primarily research-based and not yet mainstream in conventional oncology, several US-based integrative oncologists and cancer specialists incorporate similar ketogenic metabolic therapies inspired by Seyfried's work. These practitioners often blend it with standard treatments.
Traditional board-certified oncologists (MDs) explicitly referencing the full Press-Pulse protocol are rare, as it's still experimental. However, the following professionals demonstrate understanding through their use of ketogenic diets, glucose restriction, and metabolic targeting—core elements of Seyfried's framework. We've prioritized MD oncologists where possible and included integrative clinics that cite Seyfried directly.
  • Dr. Dawn Lemanne, MD
    Oregon Integrative Oncology
    Credentials & Expertise: Board-certified medical oncologist (trained at Stanford); specializes in evidence-based integrative cancer care, including personalized ketogenic diets for tumor types like brain cancers and cachexia management. Monitors glucose-ketone index (GKI) for optimal ketosis during radiation/chemo.
    Location: Ashland, OR
    Contact/Details: Phone: (541) 488-6261; Website: oregonio.com; Address: 149 Clear Creek Drive, Ashland, OR 97520
    Connection to Seyfried/Press-Pulse: Uses ketogenic metabolic therapy aligned with Seyfried's glucose restriction principles; no direct Press-Pulse mention, but integrates fasting and anti-inflammatory strategies to target cancer metabolism.
  • Root Causes MD Integrative Oncology
    (Drs. Nasha Winters, Paul Anderson, Neil McKinney)
    Credentials & Expertise: Metabolic oncology focus; Dr. Winters (ND, FABNO) leads with "Terrain 10" framework for metabolic cancer care; Dr. Anderson (ND, FABNO) uses IV therapies; Dr. McKinney (ND) emphasizes botanicals/detox. Not all MDs, but clinic collaborates with oncologists.
    Location: Fort Myers, FL
    Contact/Details: Phone: Not listed (contact via site); Website: rtcausesmd.com; Address: 12734 Kenwood Lane #56, Fort Myers, FL 33907
    Connection to Seyfried/Press-Pulse: Explicitly references Seyfried's metabolic theory (e.g., glucose fermentation in cancer cells) and uses ketogenic/low-carb diets to "starve" tumors, aligning with Press-Pulse's glucose restriction; combines with hyperthermia, IV nutrients, and mistletoe for pulsed interventions.
  • Dr. Ian D. Bier, ND, PhD, LAc, FABNO
    Human Nature Natural Health
    Credentials & Expertise: Naturopathic oncologist with fellowship in integrative cancer therapy; extensive experience in ketogenic diets combined with hyperbaric oxygen (HBO) for metastatic cancers.
    Location: Portsmouth, NH
    Contact/Details: Phone: (603) 610-7778; Website: humannaturenaturalhealth.com; Address: 155 Borthwick Ave, Ste W102, Portsmouth, NH 03801
    Connection to Seyfried/Press-Pulse: Applies ketogenic metabolic therapy synergistically with HBO (a key "pulse" element in Seyfried's protocol) to enhance anti-cancer effects; cites studies on KD + HBO for tumor reduction.
  • Dr. Mel Schottenstein, NMD, MBE, MScN
    Mitogenesis
    Credentials & Expertise: Naturopathic doctor with fellowship in integrative cancer therapy; develops personalized metabolic plans targeting mitochondrial dysfunction.
    Location: Scottsdale, AZ
    Contact/Details: Phone: Not listed (contact via site); Website: mitogenesis.health; Address: Scottsdale, AZ (exact not specified)
    Connection to Seyfried/Press-Pulse: Directly cites Seyfried's theory on cancer as a metabolic disease (glucose fermentation without oxygen); uses low-carb/high-fat nutrition for glucose restriction, core to Press-Pulse.
  • Other Resource Links:
Related: Cancer as a Metabolic & Immune Disease: Diet, Drugs, and Science Explained (2026 Public Guide)

What is Integrative Oncology?

Integrative medicine combines conventional Western medicine with complementary and alternative treatments that have been researched and proven to be safe and effective in healing. Integrative oncology uses integrative medicine as part of standard cancer care.

"Integrative oncology is a practice where we use lifestyle medicine like dietary modifications, stress reduction, exercise, supplements and mind-body practices," saysStacy D'Andre, M.D., a Mayo Clinic medical and integrative oncologist. "We combine all of these practices to help our cancer patients improve quality of life and hopefully improve treatment outcomes, as well."

Integrative oncology is a patient-centered, evidence-based field of cancer care that utilizes mind and body practices, natural products, and/or lifestyle modifications from different traditions alongside conventional cancer treatments. Integrative oncology aims to optimize health, quality of life, and clinical outcomes across the cancer care continuum and to empower people to prevent cancer and become active participants before, during, and beyond cancer treatment.

integrative oncology

But which - or who do you choose? 

First of all, you could begin by treating all of the clinics and specialists listed as though you are interviewing them for a very important position (which is, in fact, exactly what you are doing!)

Then there are some key questions to be asked.
  1. How many patients have been treated with your sort of cancer at the level and stage of your cancer?

  2. What have the results been?  You need specifics on this, for example, how many patients are still being monitored/checked in on?  How long have they been monitored for? What kind of regime did they do? 

  3. When the programme hasn’t worked, what have the factors been that led to that?

  4. How long do I need to do this programme for?

  5. How easy is it to do at home?

  6. Will I need help to do it at home?

  7. How much will it all cost? Factor in consultancy fees, travel, cost of supplements and different treatments over the time you might be doing the programme.

  8. Do you LIKE the practitioner and feel you could have a good relationship with them?  It’s really important that you trust the person/organisation and their style of working fits well with yours. 

  9. Do they have anyone they could refer you to to discuss their experience?  This is especially important if you are going abroad for your treatment.  Finding someone at home who has been there and done it can be very reassuring.
Some people have found it helpful to get a friend or two to do the initial checking out. Then you can compare the information you get before making your own personal contact. 

Read More: Integrative Oncology Explained – What evidence‑based integration actually means


Related: 



New & Improved Joe Tippens Protocol

In 2016, Joe Tippens was diagnosed with non-small-cell lung cancer with extensive metastatic disease. At the advice of a veterinarian friend, he took Fenbendazole together with nanocurcumin, and three months after starting these drugs his PET scan was completely clear.

Below is a modified version of the Joe Tippens protocol, a synergistic combination of fenbendazole, ivermectin and nutraceuticals, updated based on the ivermectin and mebendazole based protocol published in the Journal of Orthomolecular Medicine (2024):
  • Ivermectin (25 mg, 6 days a week) or in the case of severe aggressive cancers up to 1mg/kg/day.
  • Mebendazole (Dose of 250 - 500 mg/day) or Fenbendazole, commonly taken at 300 mg for six days a week, with doses increasing to up to 1 gram in cases of aggressive cancers.
  • Vitamin D (62.5 mcg [2500 IU] seven days a week).
  • Bio-Available Curcumin (600 mg per day, 7 days a week). 
  • Enhanced absorption Berberine (500 mg per day) to starve your cancer of sugar.
  • Diet and Lifestyle: Eliminate sugar (BMJ 2023), adopt a whole-food diet, avoid ultra-processed foods (BMJ 2024) and a healthy lifestyle with quality sleep and proper stress management. 
*Notes:
  • Please note that this protocol now includes the vital Vitamin D addition, with the one day off for the fenbendazole administration. This protocol represents the most comprehensive and cutting edge repurposed drug and vitamin treatment approach to date.
  • If you are taking ivermectin and mebendazole, you might not need fenbendazole. Consult your doctor.
  • Vitamin E: Removed from the protocol (Joe Tippens, July 22, 2020) due to interactions (e.g., with blood thinners).


Ivermectin and mebendazole, both approved for human use, are now available in the U.S.

Researched and approved by Dr. Peter McCullough.
  • Prescribed by licensed medical professionals
  • Compounded and dispensed by a licensed US-based pharmacy
  • Approved for human use
Where to buy Ivermectin and Mebendazole Formula: Available on The Wellness Company's website. Here is the link: Ivermectin and Mebendazole.

Comments

  1. CanoeingCanuckJanuary 1, 2025 at 9:28 AM

    Hi Dr. Yap - this is fabulous information - what is your background and do you do consultations?

    ReplyDelete

Post a Comment

Popular posts from this blog

Ivermectin for Cancer Treatment: Protocols and Evidence (2025 Edition)

By Editorial Team
Image
Ivermectin, a drug primarily used to treat parasitic infections, has gained attention for its potential anti-cancer properties, particularly in alternative treatment protocols. Popularized by figures like Dr. William Makis, these protocols combine ivermectin with supplements and lifestyle changes to target aggressive cancers. This article explores the science, protocols, case reports, risks, and controversies surrounding ivermectin’s use in cancer treatment, providing a balanced guide for readers. What is the Ivermectin Cancer Protocol? Ivermectin cancer protocols, notably those developed by Dr. William Makis, combine ivermectin with supplements like curcumin, vitamin D, and berberine, alongside dietary and lifestyle changes. These protocols are tailored to cancer severity, with higher doses recommended for aggressive cases. The term “turbo cancers,” used by some proponents, refers to rapidly progressing cancers, though it is not a standard medical term and lacks clear scientific defin...
Read more

Exploring Ivermectin, Mebendazole and Fenbendazole as Aggressive Cancer Treatments: Research, Protocols, and Controversies (2025)

By Editorial Team
Image
Fenbendazole and ivermectin, both antiparasitic drugs that have shown potential in cancer treatment through several mechanisms, such as slowing cancer cell growth and boosting the immune response. Fenbendazole is being studied for its ability to disrupt energy production in cancer cells, effectively hindering their growth. Ivermectin, on the other hand, has been explored in combination with checkpoint inhibitors to boost the immune system's response to tumors—especially in challenging cases like triple-negative breast cancer. Introduction Cancer remains a leading cause of morbidity and mortality worldwide, with an increasing incidence of aggressive and treatment-resistant tumors such as triple-negative breast cancer (TNBC), pancreatic adenocarcinoma, and glioblastoma. Despite significant advances in targeted therapies and immunotherapies, many patients continue to face limited effective options, highlighting an urgent need for novel, affordable, and accessible treatment strategies....
Read more

Fenbendazole and Ivermectin for Cancer: A Case Series of Over 360 Patients (2026)

By Editorial Team
Image
Anecdotal reports and preliminary studies suggest that ivermectin and fenbendazole, both antiparasitic drugs, may have potential anticancer effects when used alongside other treatments.  Many people immediately dismiss the potential of ivermectin and fenbendazole when they learn it is “horse or dog medicine”. That initial reaction is overcome when genuine human success stories are told including the lack of serious side effects. The testimonials you are about to read are from individuals who have bravely shared their experiences in the hope of inspiring and uplifting others. These are raw human accounts, unfiltered by gatekeepers—not peer-reviewed studies—but they offer insights that may be valuable to those searching for options. However, we acknowledge that robust clinical trials are needed to provide more conclusive scientific evidence. Contents: Editor's Preface Introduction Fenbendazole and Ivermectin Case Series Compilation (alphabetical) Breast Cancer Success Stories  (...
Read more

Fenbendazole and the Joe Tippens Protocol: Evidence, Risks, and Current Perspective (2026 Update)

By Editorial Team
Image
Introduction The Joe Tippens Protocol revolves around the off-label use of fenbendazole (a veterinary dewormer commonly sold as Panacur C or Safe-Guard) combined with various supplements for cancer. Joe Tippens popularized this approach after claiming it contributed to his remission from metastatic small-cell lung cancer in 2017. As of 2025, Joe Tippens remains alive and reports being cancer-free for over 8 years, continuing a maintenance version of the protocol. Fenbendazole is marketed for animals (e.g., Panacur C, Safe-Guard ) and has no regulatory approval for human cancer treatment . Evidence for anticancer effects is primarily preclinical or anecdotal , and clinical trials in humans are lacking. Important Disclaimer: Fenbendazole is not approved by the FDA, EMA, or any regulatory body for human use or cancer treatment. There are no completed randomized controlled human clinical trials demonstrating its safety or efficacy against cancer. All human evidence is anecdotal, from case...
Read more

Fenbendazole vs Ivermectin for Cancer: Differences and Which Is Better?

By Editorial Team
Image
Cancer patients are increasingly inquiring about the use of the anthelmintic drugs Fenbendazole (FenBen) and Ivermectin (IVM) as potential treatments for cancer. Notably, these patients typically fall into two distinct groups, neither of which represents the usual stage 1 or 2 cancer cases where conventional therapies often show promise. The first group consists of older men whose lung or prostate cancer has recurred. Having undergone conventional treatments previously without success, they express skepticism about its effectiveness this time around. The second, larger group comprises younger patients under 40 dealing with aggressive breast cancer, colorectal cancer, or lymphoma—forms of early-onset cancers that appear to lack the typical mutations observed in traditional cases. This article aims to delve into the differences between Fenbendazole and Ivermectin by examining their me...
Read more

Top 10 Cancer Fighting Supplements: Evidence Based Literature Review (2025)

By Editorial Team
Image
Are you overwhelmed by conflicting advice on cancer, diet, and supplements ? You’re not alone. With so many claims out there, it’s hard to separate fact from fiction . Can certain foods lower your cancer risk ? Are some foods increasing it without you realizing? What about vitamin and mineral supplements —do they help prevent cancer, or could they actually increase your risk ? The term " anti-cancer supplements " can be misleading. While some nutrients support the body in cancer prevention or treatment, others may interfere with therapies or even pose risks. There are presently over 1,500 herbs and food supplements in commerce, many of them with claims in use against cancer. This guide compiles over 500 scientific r...
Read more

Fact Check: Can Ivermectin and Fenbendazole Help Treat Cancer?

By Editorial Team
Image
Ivermectin and fenbendazole, originally developed as antiparasitic drugs, are sparking hope in the fight against cancer, fueled by inspiring stories like those shared by actor  Mel Gibson on The Joe Rogan Experience , where he celebrated friends’ remarkable recoveries. While these medications aren’t yet standard cancer treatments, early research is uncovering exciting potential. Scientists are encouraged by promising lab studies and are calling for more clinical trials to confirm their effectiveness and ensure safe use in humans, paving the way for innovative, accessible therapies that could transform lives. Introduction and Context According to a January 22, 2025 fact-check article by AFP: "The anti-parasitic drugs ivermectin and fenbendazole are not currently recommended for cancer, but posts spread across social media touting the medications after actor  Mel Gibson claimed on the Joe Rogan Experience  that they cured his friends' cases of the disease. Oncology ex...
Read more

Fenbendazole and Cancer: What the Science Really Shows (Evidence, Risks & Open Questions)

By Editorial Team
Image
Abstract Background:  Fenbendazole (FBZ), a benzimidazole anthelmintic approved for veterinary use, has attracted attention for potential anticancer activity based on laboratory findings and widespread anecdotal reports.  Objective:  To critically appraise the current evidence on fenbendazole and cancer using a peer‑review style framework.  Methods:  Narrative review of preclinical studies, publicly reported human case narratives, and safety signals, with emphasis on evidence hierarchy and translational limitations.  Results:  Preclinical data demonstrate antiproliferative effects via microtubule disruption and metabolic stress in vitro and in animal models. Human evidence is limited to uncontrolled case reports; no Phase I–III clinical trials or regulatory approvals for oncology exist. Safety data in humans are sparse, with hepatotoxicity signals reported.  Conclusions:  Fenben...
Read more

Best Fenbendazole Dosage for Cancer in Humans: Benefits, Risks, and Guidelines (2025)

By Editorial Team
Image
What is Fenbendazole? Fenbendazole is a broad spectrum anti-parasitic used against gastrointestinal parasites including: giardia, roundworms, hookworms, whipworms, the tapeworm genus Taenia (but not effective against Dipylidium caninum, a common dog tapeworm), pinworms, aelurostrongylus, paragonimiasis, strongyles, and strongyloides that can be administered to sheep, cattle, horses, fish, dogs, cats, rabbits, most reptiles, freshwater shrimp tanks as planaria and hydra treatments, as well as seals. (2) Fenbendazole, has garnered ⁤attention​ for its potential use ​in‍ humans.‍ The Fenbendazole Cancer Protocol gained rapid interest over the past years following some  fenbendazole advanced cancer success stories . Joe Tippens founded the protocol  after he was told a story about a scientist at Merck Animal Health that had been performing cancer research on mice. The research included injecting different types of cancers into different mice body parts. The scientists discover...
Read more

2025 Study: Ivermectin and Balstilimab for Stage 4 Triple Negative Breast Cancer - Cedars-Sinai Medical Center Study

By Editorial Team
Image
Authors: Yuan Yuan, Jin Sun Bitar, MaLia Walker, David Lin, January Lee, So Yung Choi, Stephen Shiao, Mourad Tighiouart, Paul H. Frankel, Peter P. Lee Affiliation: Cedars-Sinai Medical Center, Los Angeles, CA Abstract e13146  (2025 ASCO Annual Meeting) is a phase 1/2 study of ivermectin in combination with balstilimab after 1-2 prior lines of therapy for triple negative breast cancer Background: Despite recent FDA approval of immune checkpoint inhibitor (ICI) and antibody-drug conjugates (ADCs), therapeutic options for metastatic triple negative breast cancer (mTNBC) remain limited. Preclinical data showed that ivermectin induces robust T cell infiltration into breast tumors and turning “cold” tumors “hot” in mouse model of TNBC. Balstilimab is a fully humanized IgG4 anti-PD-1 agent with proven safety and efficacy in metastatic cervical cancer. The current phase I/II trial is designed to test the safety and efficacy of the combination of ivermectin and balstilimab in patients wit...
Read more